Single Biggest Cancer Dictionary in the World
What is
neoantigen-based therapeutic cancer vaccine GRT-C903
?Pronunciation: /neoantigen* beɪst ˌθɛrəˈpjutɪk ˈkænsər ˌvækˈsin grt* si naɪn ˈhənərd ənd θri/
neoantigen-based therapeutic cancer vaccine GRT-C903
Definition
A cancer priming vaccine consisting of tumor-specific shared neoantigens, which are immunogenic and unique across a subset of patients, with potential immunostimulating and antineoplastic activities. Upon administration of neoantigen-based therapeutic cancer vaccine GRT-C903, followed by the boosting vaccine GRT-R904, the peptides stimulate the host immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against the shared neoantigens expressed on tumor cells, which results in tumor cell lysis.